In last trading session, ProKidney Corp (NASDAQ:PROK) saw 0.44 million shares changing hands with its beta currently measuring 1.37. Company’s recent per share price level of $1.85 trading at -$0.03 or -1.60% at ring of the bell on the day assigns it a market valuation of $539.66M. That closing price of PROK’s stock is at a discount of -140.0% from its 52-week high price of $4.44 and is indicating a premium of 36.22% from its 52-week low price of $1.18. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.42 million shares which gives us an average trading volume of 688.38K if we extend that period to 3-months.

For ProKidney Corp (PROK), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.15 in the current quarter.

ProKidney Corp (NASDAQ:PROK) trade information

Upright in the red during last session for losing -1.60%, in the last five days PROK remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $1.85 price level, adding 5.13% to its value on the day. ProKidney Corp’s shares saw a change of 3.93% in year-to-date performance and have moved 12.12% in past 5-day. ProKidney Corp (NASDAQ:PROK) showed a performance of 7.56% in past 30-days. Number of shares sold short was 10.7 million shares which calculate 25.42 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 63.0% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -62.16% in reaching the projected high whereas dropping to the targeted low would mean a loss of -62.16% for stock’s current value.

ProKidney Corp (PROK) estimates and forecasts

Statistics highlight that ProKidney Corp is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -55.95% of value to its shares in past 6 months, showing an annual growth rate of 0.00% while that of industry is 17.00.

ProKidney Corp (NASDAQ:PROK)’s Major holders

Insiders are in possession of 27.44% of company’s total shares while institution are holding 43.59 percent of that, with stock having share float percentage of 60.07%. Investors also watch the number of corporate investors in a company very closely, which is 43.59% institutions for ProKidney Corp that are currently holding shares of the company.